Abstract
Hypoglycaemia remains a serious and much feared complication of insulin therapy. In this study, patients attending an accident and emergency department in hypoglycaemic coma were randomized to treatment with either intravenous dextrose (25g) or intramuscular glucagon (1mg), administered into the right thigh. Restoration of normal conscious level was slower after glucagon than dextrose (9.0 vs 3.0 min, P less than 0.01), although the average duration of hypoglycaemic coma was 120 min. Two patients in the glucagon-treated group, who failed to show satisfactory recovery after 15 min, required additional treatment with intravenous dextrose. On questioning following recovery, all except two patients reported loss of awareness of the onset of hypoglycaemia Intramuscular glucagon is valuable in the treatment of severe hypoglycaemia outwith hospital and, although the slightly slower and less predictable recovery may appear to make it a less attractive option than intravenous dextrose in the accident and emergency department, this must be balanced against the advantages of ease of administration and a lower incidence of serious adverse effects.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aman J., Wranne L. Hypoglycaemia in childhood diabetes. II. Effect of subcutaneous or intramuscular injection of different doses of glucagon. Acta Paediatr Scand. 1988 Jul;77(4):548–553. doi: 10.1111/j.1651-2227.1988.tb10698.x. [DOI] [PubMed] [Google Scholar]
- Amiel S. A., Tamborlane W. V., Simonson D. C., Sherwin R. S. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med. 1987 May 28;316(22):1376–1383. doi: 10.1056/NEJM198705283162205. [DOI] [PubMed] [Google Scholar]
- Casparie A. F., Elving L. D. Severe hypoglycemia in diabetic patients: frequency, causes, prevention. Diabetes Care. 1985 Mar-Apr;8(2):141–145. doi: 10.2337/diacare.8.2.141. [DOI] [PubMed] [Google Scholar]
- Collier A., Steedman D. J., Patrick A. W., Nimmo G. R., Matthews D. M., MacIntyre C. C., Little K., Clarke B. F. Comparison of intravenous glucagon and dextrose in treatment of severe hypoglycemia in an accident and emergency department. Diabetes Care. 1987 Nov-Dec;10(6):712–715. doi: 10.2337/diacare.10.6.712. [DOI] [PubMed] [Google Scholar]
- ELRICK H., WITTEN T. A., ARAI Y. Glucagon treatment of insulin reactions. N Engl J Med. 1958 Mar 6;258(10):476–480. doi: 10.1056/NEJM195803062581005. [DOI] [PubMed] [Google Scholar]
- Matthews D. M., Patrick A. W., Collier D. A., Kellett H. A., Steel J. M., Clarke B. F., MacIntyre C. C. Awareness and use of glucagon in diabetics treated with insulin. Br Med J (Clin Res Ed) 1986 Aug 9;293(6543):367–368. doi: 10.1136/bmj.293.6543.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mühlhauser I., Koch J., Berger M. Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous, and intravenous administration. Diabetes Care. 1985 Jan-Feb;8(1):39–42. doi: 10.2337/diacare.8.1.39. [DOI] [PubMed] [Google Scholar]
- Potter J., Clarke P., Gale E. A., Dave S. H., Tattersall R. B. Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J (Clin Res Ed) 1982 Oct 23;285(6349):1180–1182. doi: 10.1136/bmj.285.6349.1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SHIPP J. C., DELCHER H. K., MUNROE J. F. TREATMENT OF INSULIN HYPOGLYCEMIA IN DIABETIC CAMPERS; A COMPARISON OF GLUCAGON (1 AND 2 MG.) AND GLUCOSE. Diabetes. 1964 Nov-Dec;13:645–648. doi: 10.2337/diab.13.6.645. [DOI] [PubMed] [Google Scholar]
- Tunbridge W. M. Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association. Lancet. 1981 Sep 12;2(8246):569–572. doi: 10.1016/s0140-6736(81)90950-8. [DOI] [PubMed] [Google Scholar]